New Research May Help Save Athletes’ Brains

By Maura Murphy As we enter week 5 of the National Football League (NFL) season, there is immense controversy over whether players should kneel during the national anthem. What fewer people are talking about, however, is the way the game affects the overall health of these athletes. Last Tuesday, Boston University (BU) published a new […]

Hold Your Horses! Donating Blood Over Time Is Just as Important as Donating After Disasters

By Brian Flach for BioLawToday.org By now, everyone has seen the fallout of Hurricane Harvey. The acts of heroism, the widespread destruction, but most importantly, the reminders that we as people want to help each other. This is evident in how blood drives seem to spring up overnight, both locally and across the country, to […]

Is There a Fourth Amendment Expectation of Privacy in Prescription Records? According to the Utah District Court, Maybe Not

By Leslie Francis, as originally posted on Harvard Law School’s Bill of Health blog. It might come as a surprise to many in the United States that they may have no Fourth Amendment reasonable expectation of privacy in their physicians’ records when their physicians transfer these records to state agencies under state public health laws. […]

The Clean Air Act: Improving public health at an affordable cost

By Michael Squires At its core, the Clean Air Act (CAA) is a health care statute. Congress found that “the growth in the amount and complexity of air pollution brought about by urbanization, industrial development, and the increasing use of motor vehicles, has resulted in mounting dangers to the public health and welfare.”[1] In 1990 […]

President Trump’s Proposed Budget Cuts to the National Institutes of Health

By Alexis Juergens for BioLawToday.org. President Trump released his preliminary 2018 budget plan on March 15th. While the budget plan proposes decreased federal funding in several areas, one of the agency’s receiving a cut in their budget is the National Institute of Health (“NIH”). The budget proposes to reduce NIH funding by 18%; this equates […]

Reproductive rights and equality under challenge in the U.S.

By Leslie Francis, originally posted on OUPblog.  For the over 40 years since the U.S. Supreme Court’s decision in Roe v. Wade that people have a constitutionally protected interest in deciding whether or not to reproduce, reproductive rights have been a persistent flashpoint of controversy in the United States. The controversy has been characterized by more heat […]

Governing Digitally Integrated Genetic Resources

By Jorge Contreras for BiolawToday.org.  In a recent case, a French research institute agreed to share the benefits arising from a drug patent with an indigenous group in French Guinea. The French researchers had learned about the medicinal plant from members of the Kali’na, Palikur, and Creole communities, but failed to negotiate access and benefit sharing […]

New research explores impact of broadening CRISPR patents

New research published by University of Utah S.J. Quinney College of Law Associate Professor Jorge Contreras in the journal Science proposes that universities currently holding CRISPR patents open their licenses to broader segments of the biopharma industry —a change that could potentially lead to important discoveries for human health and medicine.   “Because the potential for […]

Melinda Fagan on The Battle for CRISPR

By Justin R. Hamady for BiolawToday.org. On October 20th, the Center for Law and Biomedical Sciences at the S.J. Quinney College of Law, hosted guest speaker Melinda Fagan. Fagan holds the Sterling McMurrin Chair in the Department of Philosophy at the University of Utah and focuses her research on the philosophy of science, including explanation […]

New research explores impact of broadening CRISPR patents

New research published by University of Utah S.J. Quinney College of Law Associate Professor Jorge Contreras in the journal Science proposes that universities currently holding CRISPR patents open their licenses to broader segments of the biopharma industry —a change that could potentially lead to important discoveries for human health and medicine.   “Because the potential for […]